Working… Menu

Clinical Study Evaluating Efficacy and Safety of T3D-959 in Mild-to-moderate AD Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04251182
Recruitment Status : Recruiting
First Posted : January 31, 2020
Last Update Posted : April 15, 2021
National Institute on Aging (NIA)
Clinilabs, Inc.
Alzheimer's Association
Information provided by (Responsible Party):
T3D Therapeutics, Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 2022
Estimated Study Completion Date : July 2022